Pegcetacoplan (Syfovre; Apellis Pharmaceuticals Inc.) is a complement inhibitor indicated for the treatment of geographic atrophy secondary to age-related macular degeneration.
If you have a Hayes login, click here to view the full report on the Knowledge Center.